News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Mike Thompson: Post-ASCT Maintenance in Myeloma Using Minimal Residual Disease
Mike Thompson/LinkedIn
Oct 27, 2024, 17:41

Mike Thompson: Post-ASCT Maintenance in Myeloma Using Minimal Residual Disease

Mike Thompson, Vice President of Clinical Partnerships at Tempus AI, shared on X:

“S1803 Ph3 Len +/- Daratumumab/rhuph20 as Post-ASCT Maintenance in Myeloma Using Minimal Residual Disease to direct Therapy Duration (DRAMMATIC) – Amrita Krishnan, Hoering, Phari, Sexton, Robert Z. Orlowski.

ASH20 Abstract 1515

1515 Phase III Study of Daratumumab/rhuph20 (nsc- 810307) + Lenalidomide or Lenalidomide As Post-Autologous Stem Cell Transplant Maintenance Therapyin Patients with Multiple Myeloma (mm) Using Minimal Residual Disease Todirect Therapy Duration (DRAMMATIC study): SWOG s1803

Authors: Amrita Krishnan, Antje Hoering, Parameswaran Hari, Rachael Sexton, Robert Z. Orlowski

Mike Thompson: Post-ASCT Maintenance in Myeloma Using Minimal Residual Disease

Amrita Krishnan Antje Hoering cancer Mike Thompson Myeloma OncoDaily Oncology Parameswaran Hari Rachael Sexton Robert Z. Orlowski
Special Coverage
Insight
Dec 25, 2024, 03:00
Mazyar Shadman: Venetoclax - based therapy after cBTKi in CLL led by Nilanjan Ghosh
Insight
Dec 25, 2024, 02:57
Jarushka Naidoo: Important paper on incidence and outcomes of EGFR+ NSCLC
Insight
Dec 25, 2024, 02:41
Correlating PSA Dynamics with Outcomes of Lutetium-177-PSMA-617 Treatment - European Urology
Science
Dec 25, 2024, 02:35
Hospital Participation in the Acute Hospital Care at Home Waiver Program by Hashem Zikry et al.
Science
Dec 25, 2024, 01:52
Erman Akkus: Role of PD-L1 expression in advanced esophageal SCC by Manavi Sachdeva et al.
Blog
Dec 25, 2024, 01:50
Results of SISAQOL-IMI: Advancing Patient-Reported Outcomes Research
Science
Dec 24, 2024, 23:45
Tatiana Prowell: Genomic profiling performed on 822 breast cancer brain metastases by Athina Giannoudis et al.
Blog
Dec 24, 2024, 23:42
Extending the pandemic-era telehealth flexibilities in Medicare - ASCO
Science
Dec 24, 2024, 23:36
Drew Moghanaki: An updated report from the MISSILE study team
Science
Dec 24, 2024, 23:31
Bladder-sparing Therapy for BCG-unresponsive Non-muscle-invasive Bladder Cancer
Insight
Dec 24, 2024, 23:29
Mark Bolton: What if patients switch treatment at progression
Blog
Dec 24, 2024, 23:27
Give the gift of hope, brighter futures, and more time for patients and families - The Leukemia And Lymphoma Society